EUVIMEDEUVIMED entdecken
Crossref

Hepatocyte-Targeted Cyclic Peptide LYTACs for PCSK9 Degradation and LDL Cholesterol Metabolic Regulation

Bin Feng iD, Yiling Shi, Jingjie Xu, Mingxing Hu, Shanshan Liang, Yujue Li iD, Wei Gan

ACS Chemical Biology · 17.04.2026 · 21 (4) · 801-811

DOI: 10.1021/acschembio.6c00029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 31.03.2026. Verfasst von Bin Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Hepatocytes, Lysosomes, Cholesterol, LDL. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9HepatocytesLysosomesCholesterol, LDLPeptides, CyclicHumansAnimalsMiceProteolysis

Substanzen

Proprotein Convertase 9Cholesterol, LDLPeptides, CyclicPCSK9 protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Sichuan Clinical Research Center for Laboratory Medicine and Clinical Laboratory Medicine Research Center of West China Hospital, Chengdu 610041, China.
  • Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Nuclear Medicine and Clinical Nuclear Medicine Research Lab, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

ORCID-Profile: Bin Feng, Yujue Li

Förderung

  • West China Hospital, Sichuan University

Zitieren

APA

Feng, B., Shi, Y., Xu, J., Hu, M., Liang, S., Li, Y., & Gan, W. (2026). Hepatocyte-Targeted Cyclic Peptide LYTACs for PCSK9 Degradation and LDL Cholesterol Metabolic Regulation. ACS Chemical Biology, 21(4), 801-811. https://doi.org/10.1021/acschembio.6c00029

Vancouver

Feng B, Shi Y, Xu J, Hu M, Liang S, Li Y, et al. Hepatocyte-Targeted Cyclic Peptide LYTACs for PCSK9 Degradation and LDL Cholesterol Metabolic Regulation. ACS Chemical Biology. 2026;21(4):801-811. doi:10.1021/acschembio.6c00029

BibTeX
@article{Feng2026,
  author = {Feng, Bin and Shi, Yiling and Xu, Jingjie and Hu, Mingxing and Liang, Shanshan and Li, Yujue and Gan, Wei},
  title = {Hepatocyte-Targeted Cyclic Peptide LYTACs for PCSK9 Degradation and LDL Cholesterol Metabolic Regulation},
  journal = {ACS Chemical Biology},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {801--811},
  doi = {10.1021/acschembio.6c00029}
}
Kostenlos starten →